Debt-to-equity of Arcturus Therapeutics Holdings Inc. from 31 Mar 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Arcturus Therapeutics Holdings Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2020 to 31 Dec 2025.
  • Arcturus Therapeutics Holdings Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 32%, a 33% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Arcturus Therapeutics Holdings Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 32% -16% -33% 31 Dec 2025
Q3 2025 36% -15% -29% 30 Sep 2025
Q2 2025 40% -17% -29% 30 Jun 2025
Q1 2025 44% -13% -22% 31 Mar 2025
Q4 2024 48% -4% -7.7% 31 Dec 2024
Q3 2024 51% -4.1% -7.4% 30 Sep 2024
Q2 2024 57% -3% -5% 30 Jun 2024
Q1 2024 57% -13% -18% 31 Mar 2024
Q4 2023 52% -32% -38% 31 Dec 2023
Q3 2023 55% -32% -37% 30 Sep 2023
Q2 2023 60% -19% -24% 30 Jun 2023
Q1 2023 69% +3.9% +6% 31 Mar 2023
Q4 2022 84% +31% +58% 31 Dec 2022
Q3 2022 87% +47% +117% 30 Sep 2022
Q2 2022 79% +47% +151% 30 Jun 2022
Q1 2022 66% +36% +122% 31 Mar 2022
Q4 2021 53% +21% +63% 31 Dec 2021
Q3 2021 40% -17% -30% 30 Sep 2021
Q2 2021 31% -96% -75% 30 Jun 2021
Q1 2021 30% -182% -86% 31 Mar 2021
Q4 2020 33% 31 Dec 2020
Q3 2020 58% 30 Sep 2020
Q2 2020 127% 30 Jun 2020
Q1 2020 212% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.